Hematologic Disorders Archives - Page 80 of 81 - MPR

Hematologic Disorders

VTE Risk Varies by Hormone Therapy Formulation

VTE Risk Varies by Hormone Therapy Formulation

The risk of venous thromboembolism (VTE) in postmenopausal women differs considerably according to the formulation of hormone therapy (HT) used, with the highest VTE risk seen in users of oral estrogen-progestin HT containing medroxyprogesterone acetate.